Cargando…

Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells

Intestinal barrier dysfunction is an important clinical problem in various acute and chronic pathological conditions. Ferulic acid (FA) can attenuate the intestinal epithelial barrier dysfunction, however, the underlying mechanism remains unclear. The present study aimed to uncover the protective ef...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Shasha, Guo, Yuhong, Zhao, Jingxia, Xu, Xiaolong, Wang, Ning, Liu, Qingquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145943/
https://www.ncbi.nlm.nih.gov/pubmed/32308620
http://dx.doi.org/10.3389/fphar.2020.00376
_version_ 1783520090265747456
author He, Shasha
Guo, Yuhong
Zhao, Jingxia
Xu, Xiaolong
Wang, Ning
Liu, Qingquan
author_facet He, Shasha
Guo, Yuhong
Zhao, Jingxia
Xu, Xiaolong
Wang, Ning
Liu, Qingquan
author_sort He, Shasha
collection PubMed
description Intestinal barrier dysfunction is an important clinical problem in various acute and chronic pathological conditions. Ferulic acid (FA) can attenuate the intestinal epithelial barrier dysfunction, however, the underlying mechanism remains unclear. The present study aimed to uncover the protective effect of FA on intestinal epithelial barrier dysfunction in a Caco-2 cell model of lipopolysaccharide (LPS) stimulation and the underlying mechanism. Caco-2 cells were pretreated with FA and then exposed to LPS stimulation. The barrier function of Caco-2 cells was evaluated by measuring trans-epithelial resistance (TER) and 4-kDa fluorescein isothiocyanate (FITC)-dextran (FD4) flux, and analyzing the tight junction protein expression and structure. The results showed that decreased TER and increased FITC-FD4 flux were observed in Caco-2 cells stimulated with LPS, but these effects were attenuated by FA pretreatment. FA pretreatment inhibited LPS-induced decrease in occludin and ZO-1 mRNA and protein expression. LPS stimulation decreased miR-200c-3p expression, whereas this decrease was inhibited by FA pretreatment. Furthermore, overexpression of miR-200c-3p strengthened the protective effects of FA on LPS-induced Caco-2 cell barrier dysfunction by decreasing epithelial permeability, increasing occludin and ZO-1 protein expression, and maintaining of ZO-1 protein distribution, while suppression of miR-200c-3p reversed the protective effects of FA. LPS treatment increased the expression of PTEN protein and decreased expression of phosphorylated PI3K and AKT proteins. However, pretreatment of FA inhibited expression of PTEN protein and promoted activation of PI3K/AKT signaling pathway in the LPS-treated Caco-2 cells, and this regulatory effect of FA on the PTEN/PI3K/AKT signaling pathway was strengthened or weakened by miR-200c-3p overexpression or suppression, respectively. Our findings suggested that in Caco-2 cells, FA promotes activation of PI3K/AKT pathway by miR-200c-3p-mediated suppression of the negative mediator PTEN, which, in turn, maintains TJ function and thus ameliorates LPS-induced intestinal epithelial barrier dysfunction.
format Online
Article
Text
id pubmed-7145943
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-71459432020-04-18 Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells He, Shasha Guo, Yuhong Zhao, Jingxia Xu, Xiaolong Wang, Ning Liu, Qingquan Front Pharmacol Pharmacology Intestinal barrier dysfunction is an important clinical problem in various acute and chronic pathological conditions. Ferulic acid (FA) can attenuate the intestinal epithelial barrier dysfunction, however, the underlying mechanism remains unclear. The present study aimed to uncover the protective effect of FA on intestinal epithelial barrier dysfunction in a Caco-2 cell model of lipopolysaccharide (LPS) stimulation and the underlying mechanism. Caco-2 cells were pretreated with FA and then exposed to LPS stimulation. The barrier function of Caco-2 cells was evaluated by measuring trans-epithelial resistance (TER) and 4-kDa fluorescein isothiocyanate (FITC)-dextran (FD4) flux, and analyzing the tight junction protein expression and structure. The results showed that decreased TER and increased FITC-FD4 flux were observed in Caco-2 cells stimulated with LPS, but these effects were attenuated by FA pretreatment. FA pretreatment inhibited LPS-induced decrease in occludin and ZO-1 mRNA and protein expression. LPS stimulation decreased miR-200c-3p expression, whereas this decrease was inhibited by FA pretreatment. Furthermore, overexpression of miR-200c-3p strengthened the protective effects of FA on LPS-induced Caco-2 cell barrier dysfunction by decreasing epithelial permeability, increasing occludin and ZO-1 protein expression, and maintaining of ZO-1 protein distribution, while suppression of miR-200c-3p reversed the protective effects of FA. LPS treatment increased the expression of PTEN protein and decreased expression of phosphorylated PI3K and AKT proteins. However, pretreatment of FA inhibited expression of PTEN protein and promoted activation of PI3K/AKT signaling pathway in the LPS-treated Caco-2 cells, and this regulatory effect of FA on the PTEN/PI3K/AKT signaling pathway was strengthened or weakened by miR-200c-3p overexpression or suppression, respectively. Our findings suggested that in Caco-2 cells, FA promotes activation of PI3K/AKT pathway by miR-200c-3p-mediated suppression of the negative mediator PTEN, which, in turn, maintains TJ function and thus ameliorates LPS-induced intestinal epithelial barrier dysfunction. Frontiers Media S.A. 2020-04-03 /pmc/articles/PMC7145943/ /pubmed/32308620 http://dx.doi.org/10.3389/fphar.2020.00376 Text en Copyright © 2020 He, Guo, Zhao, Xu, Wang and Liu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
He, Shasha
Guo, Yuhong
Zhao, Jingxia
Xu, Xiaolong
Wang, Ning
Liu, Qingquan
Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells
title Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells
title_full Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells
title_fullStr Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells
title_full_unstemmed Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells
title_short Ferulic Acid Ameliorates Lipopolysaccharide-Induced Barrier Dysfunction via MicroRNA-200c-3p-Mediated Activation of PI3K/AKT Pathway in Caco-2 Cells
title_sort ferulic acid ameliorates lipopolysaccharide-induced barrier dysfunction via microrna-200c-3p-mediated activation of pi3k/akt pathway in caco-2 cells
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7145943/
https://www.ncbi.nlm.nih.gov/pubmed/32308620
http://dx.doi.org/10.3389/fphar.2020.00376
work_keys_str_mv AT heshasha ferulicacidameliorateslipopolysaccharideinducedbarrierdysfunctionviamicrorna200c3pmediatedactivationofpi3kaktpathwayincaco2cells
AT guoyuhong ferulicacidameliorateslipopolysaccharideinducedbarrierdysfunctionviamicrorna200c3pmediatedactivationofpi3kaktpathwayincaco2cells
AT zhaojingxia ferulicacidameliorateslipopolysaccharideinducedbarrierdysfunctionviamicrorna200c3pmediatedactivationofpi3kaktpathwayincaco2cells
AT xuxiaolong ferulicacidameliorateslipopolysaccharideinducedbarrierdysfunctionviamicrorna200c3pmediatedactivationofpi3kaktpathwayincaco2cells
AT wangning ferulicacidameliorateslipopolysaccharideinducedbarrierdysfunctionviamicrorna200c3pmediatedactivationofpi3kaktpathwayincaco2cells
AT liuqingquan ferulicacidameliorateslipopolysaccharideinducedbarrierdysfunctionviamicrorna200c3pmediatedactivationofpi3kaktpathwayincaco2cells